Weiguo Han, PhD, serves as assistant professor, research, Department of Pharmacology and Toxicology, College of Pharmacy. He specializes in next-generation sequencing and cancer biomarker analysis and boasts extensive research and development experience in genetics, epigenetics and molecular biology. His work includes DNA, RNA miRNA, gene cloning, CRISPR/Cas9, SNP and genetic contributions to lung cancer.
Author of numerous peer-reviewed journal articles, Han holds three patents. He received a National Institutes of Health grant for gene methylation analysis, two-year grant for epigenetic lung cancer biomarker research from the American Lung Association Research Training Fellowship and Scholar-in-Training Award from the American Association for Cancer Research.
PhD, Biochemistry and Molecular Biology, Fudan University (Shanghai, China), 2001
MS, Clinical Laboratory Medicine, Chongqing University of Medical Sciences (Chongqing, China), 1991
BS, Clinical Laboratory Medicine, Zhengjiang Medical College (Jiangsu, China), 1984
Cancer biomarkers
CRISPR/Cas9, SNP
DNA/RNA methylation
Gene expression
Lung cancer
Molecular biology
Next Generation Sequencing technology